Smith & Nephew Plc

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 09:05:09 05/07/2024 pm IST			5-day change	1st Jan Change
1,057 ^GBX	+0.28%		+7.79%	-1.99%

05/07	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT
04/07	Stocks mainly green as UK election results loom	AN

Smith & Nephew jumps as Cevian Capital takes 5% stake

July 04, 2024 at 01:40 pm IST

(Alliance News) - Smith & Nephew PLC got a boost on Thursday, after activist investor Cevian Capital II GP Ltd took a stake in the firm.

Shares in the London-based medical technology company were up 6.4% at 1,049.50 pence each in London on Thursday morning.

The wider FTSE 100 index, meanwhile, was up 0.6%.

Activist investor Cevian, which holds its headquarters in Stockholm, has acquired a 5.02% stake in Smith & Nephew.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Smith & Nephew Plc

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	05/07	MT
Stocks mainly green as UK election results loom	04/07	AN
Market Update-Europe closes higher on optimism about US rates	04/07	RE
Activist Investor Cevian Capital Buys 5% Stake in Smith & Nephew	04/07	MT
London on the up as Labour predicted a majority	04/07	AN
Market Update-European stock markets rise in absence of Wall Street	04/07	RE
Smith & Nephew shares soar as activist Cevian builds stake	04/07	RE
Smith & Nephew jumps as Cevian Capital takes 5% stake	04/07	AN
FTSE 100 gets boost as Brits head to polls	04/07	AN
London's FTSE 100 climbs on Smith & Nephew boost; UK polls underway	04/07	RE
Cevian Capital II GP Limited acquired 5.02% stake in Smith & Nephew plc (LSE:SN.).	04/07	CI
Beiersdorf: gaining share in shrinking China luxury skin care market	18/06	RE
Smith & Nephew Launches Pre-Operative Planning, Modeling Services for Robotic-Assisted Surgical System	12/06	MT
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading	10/06	MT
UBS Upgrades Smith & Nephew to Buy from Neutral, Raises PT	05/06	MT
European blue-chips up ahead of likely rate cuts	05/06	AN
Berenberg raises Taylor Wimpey to 'buy'	05/06	AN
SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%)	31/05
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	14/05	MT
Smith & Nephew plc Announces Final Dividend of the Year Ended 31 December 2023, Payable on May 22, 2024	09/05	CI
SMITH & NEPHEW : Q1 24: A few positives underneath the top-line miss	09/05
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03/05	AN
Deutsche Bank likes TP ICAP but says sell CMC	02/05	AN
London Stocks Retreat as UK Manufacturing Sector Reverts to Contraction	01/05	MT
Smith & Nephew plc Provides Sales Results for the First Quarter Ended 30 March 2024	01/05	CI

Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/08/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%)

May 31, 2024 at 12:26 pm IST

More Strategies

Ratings for Smith & Nephew Plc

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.54 USD

Average target price

16.37 USD

Spread / Average Target

+20.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
SMITH & NEPHEW PLC	-1.99%	11.8B
STRYKER CORPORATION	+12.62%	128B
GLAUKOS CORPORATION	+53.19%	6.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-23.60%	6.65B
INSPIRE MEDICAL SYSTEMS, INC.	-30.75%	4.19B
ENOVIS CORPORATION	-19.96%	2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-17.14%	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-21.05%	1.75B
DOUBLE MEDICAL TECHNOLOGY INC.	-37.13%	1.45B
MEDARTIS HOLDING AG	-16.31%	1.06B

Medical Devices & Implants

Smith & Nephew Plc

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Smith & Nephew jumps as Cevian Capital takes 5% stake

Latest news about Smith & Nephew Plc

Chart Smith & Nephew Plc

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Smith & Nephew Plc

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants